EGF Theramed Health Cash Flow Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Feb '21 Feb 28, 2021
Net Income	-0.4	-0.27	-0.62	-1.35	-0.97	-0.25
Asset Writedown & Restructuring Costs	-	-	-	0.35	-	-
Stock-Based Compensation	-	-	-	-	0.07	-
Other Operating Activities	0.08	0.07	0.03	0.02	-0.24	-
Change in Accounts Receivable	0.16	-0.03	-0.02	-0.02	-0.07	-
Change in Accounts Payable	0.15	0.09	0.04	0.01	0.31	-
Change in Other Net Operating Assets	0	0.01	-0	0	0.01	0.25
Operating Cash Flow	-0.01	-0.13	-0.58	-0.99	-0.78	-0
Cash Acquisitions	-	-	-	-	0.46	-
Investing Cash Flow	-	-	-	-	0.41	-
Short-Term Debt Issued	-	0.06	0.07	0.07	-	-
Total Debt Issued	-	0.06	0.07	0.07	-	-
Net Debt Issued (Repaid)	-0.03	0.06	0.07	0.07	-	-
Issuance of Common Stock	-	0.07	0.5	0.24	0.71	1.03
Financing Cash Flow	-0.03	0.13	0.57	0.31	0.71	1.03
Net Cash Flow	-0.03	-0	-0	-0.69	0.34	1.03
Levered Free Cash Flow	0.13	-0.09	-0.22	-0.62	-	-
Unlevered Free Cash Flow	0.17	-0.05	-0.2	-0.61	-	-
Change in Net Working Capital	-0.32	-0.09	-0.02	0	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.